New assay identifies patients with altered p300/CBP acetylation in castration-resistant prostate cancer
A new research paper was published in Oncotarget's Volume 14 on July 20, 2023, entitled, "Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells."
Source: news-medical.net